Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in <i>p53</i>
Gemma L. Kelly(The University of Melbourne), Andreas Strasser(The University of Melbourne)
Cited by 169
Related Papers
The BCL-2 protein family, BH3-mimetics and cancer therapy
|Cell Death and Differentiation|2015|540
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
|Genes & Development|2012|417
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Cancer Discovery|2023|91
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins
|Cell Death and Differentiation|2019|61
Bcl-2 does not inhibit cell death induced by the physiological Fas ligand: implications for the existence of type I and type II cells
|Cell Death and Differentiation|2000|37